Assessing Limb Outcomes in Drug Trials in Peripheral Artery Disease: The Need for a Universal and Pragmatic Definition

Low-dose Colchicine in Patients with Peripheral Artery Disease to Address Residual Vascular Risk (LEADER-PAD) Study Group

doi:https://doi.org/10.1016/j.ejvs.2023.06.007

Assessing Limb Outcomes in Drug Trials in Peripheral Artery Disease: The Need for a Universal and Pragmatic Definition

DSpace/Manakin Repository

Assessing Limb Outcomes in Drug Trials in Peripheral Artery Disease: The Need for a Universal and Pragmatic Definition

Low-dose Colchicine in Patients with Peripheral Artery Disease to Address Residual Vascular Risk (LEADER-PAD) Study Group

(2023) European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, volume 66, issue 3, pp. 442 - 443

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Clinical trials, Major adverse limb events, MALE, Outcome definition, PAD, Peripheral artery disease, Cardiology and Cardiovascular Medicine, Surgery, Letter

DOI: https://doi.org/10.1016/j.ejvs.2023.06.007

ISSN: 1078-5884

Publisher: W.B. Saunders Ltd

(Peer reviewed)